New reagent for detection of program cell death

Project Details

Programmed cell death (PCD) like cell proliferation is an essential process of life. A novel reagent, a conjugate of anti-calcitonin receptor antibody and a fluorophore, has been studied and is rapidly internalised into live cells undergoing PCD (apoptosis, autophagy) in vitro. A similar reagent is being developed for detection of PCD in diseased tissues in vivo.

Our group has discovered that a novel reagent, a conjugate of anti-CTR antibody and a fluorophore AlexaFluor 568 is rapidly accumulated into cells cultured in vitro that have been induced to undergo apoptosis with cytotoxin. The result is a high fluorescence signal that can be recorded with laser activated technologies such as confocal microscopy and flow cytometry. This event overlaps the binding of annexin V and the activation of caspase 3, events previously used to determine PCD. As the antibody binds an extracellular epitope of CTR the rapid internalisation and concentration in the peri-nuclear region represents a novel event specific for PCD. The utility of similar radioactive conjugates has been proposed to image PCD in vivo and this might be useful for monitoring drug trials for the treatment of tumours and cardiovascular disease.



Postdoc support from the Australian government, philanthropic funds, funds from the pharmaceutical industry and small institutional grants.

Research Group

Cardiovascular and Tumourivascular Laboratory

Faculty Research Themes

Cancer, Infection and Immunology

School Research Themes

Cancer in Medicine, Cardiometabolic

Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Medicine and Radiology

MDHS Research library
Explore by researcher, school, project or topic.